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Abstract
Leiomyomas are the most common gynecologic and uterine neoplasms. Uterine 
leiomyomas present in approximately 25% of women during reproductive age. 
Extrauterine leiomyomas (EULs) are rarer and usually arise in the genitourinary 
tract, however, may arise at nearly any anatomic location and possess a great 
diagnostic challenge. Moreover, the EULs may also present with unusual growth 
patterns such as disseminated peritoneal leiomyomatosis, intravenous leiomyoma-
tosis, benign metastasizing leiomyoma, parasitic leiomyoma, and retroperitoneal 
mass. However, the cell of origin from smooth muscle cells and histological benign 
characteristics is similar to their uterine counterpart. The presence of a synchronous 
uterine leiomyoma or history of previous hysterectomy is a considerable evidence 
for the diagnosis of these abnormally located and unusual growth pattern display-
ing EULs. Different imaging modalities like ultrasonography, computed tomogra-
phy, and magnetic resonance imaging are helpful in the diagnosis of EULs, however, 
sometimes a histopathological examination is required for the confirmation.
Keywords: Extrauterine, leiomyoma, disseminated peritoneal leiomyomatosis, 
benign metastasizing leiomyoma, parasitic leiomyoma, genitourinary tract
1. Introduction
Leiomyomas are benign smooth muscle tumours usually arise from the uterus 
[1]. Classical uterine leiomyoma manifest as firm, well circumscribed mass, and 
localized to the pelvic cavity [2]. Extrauterine leiomyomas (EULs) are very rare and 
their etiology is not clear [1]. They grow in unusual patterns and locations, thus 
possess greater diagnostic challenge. Different presentations of EUL are dissemi-
nated peritoneal leiomyomatosis (DPL), parasitic leiomyoma (PL), uterine-like 
mass lesions, adenomyoma and endomyometriosis [3]. Unusual sites involvement 
like vulval and rectovaginal leiomyomas are also found [4]. EULs arising in the 
gastrointestinal tract, genitourinary tract, as well as other rare locations including 
sinonasal cavities, orbits, and skin are also described in some case reports.
Uterine leiomyoma is a benign tumour which originates from smooth muscle 
cells. Leiomyomas can present in abnormal growth patterns and tend to occur 
in extrauterine location especially in cases with prior history of hysterectomy or 
surgery for uterine leiomyomas.
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2. Types of EULs
2.1 Disseminated peritoneal leiomyomatosis
Multifocal proliferation of multiple smooth nodules throughout the peritoneal 
surface histologically similar to uterine myomas is known as leiomyomatosis 
peritonealis disseminate (LPD) or disseminated peritoneal leiomyomatosis (DPL) 
[3, 5, 6]. The peritoneal cavity shows multiple nodules of smooth muscle (Figure 1) 
[6, 7]. DPL usually occurs in reproductive age group with an indolent course, and 
are mostly detected incidentally [6]. Uterine myoma morcellation is a known risk 
factor for the development of DPL with an incidence rate around 0.12 to 0.95% 
after morcellation [5, 6]. Morcellation may lead to spreading of cellular materials 
of the myoma fragments. These morcellated tissues get disseminated if they are not 
removed and may become infarcted, necrotic or even parasitic [3]. Other causes 
which can contribute in the pathogenesis of DPL includes; hormonal, genetic, and 
sub-peritoneal mesenchymal stem cells metaplasia.
Pelvic region is the commonest site especially in pouch of douglas, may also 
spread to entire abdomen to involve omentum and mesentery. DPL is very invasive 
and very difficult for complete surgical excision, which may invade into blad-
der, retroperitoneal space, liver and small bowel [5]. They present as numerous 
subcentimetric grey -white firm nodules, sometimes with solid cystic hemorrhagic 
changes [5]. DPL can presents with ascites and adenopathy, which can be confused 
with peritoneal carcinomatosis. Sometimes, DPL may evolve into leiomyosarcoma, 
though it is extremely rare and possess high mortality rate [5, 6]. Due to unusual 
multifocal presentation, peritoneal myomas mimic malignant peritoneal tumor, so 
aggressive treatment at first surgical line should be avoided [6].
Some cases of gastrointestinal tract (GIT) leiomyomas have been reported with 
intestinal obstruction or bleeding without past or present history of uterine fibroid. 
But GIT leiomyomas are different from LPD. GIT leiomyomas can develop from 
intestinal wall and may reach the lumen whereas LPD mostly reach peritoneal cav-
ity and omentum [5]. But disseminated GIT leiomyoma could be related to LPD, if 
there is no evidence of uterine myomas [5].
2.2 Benign metastasizing leiomyoma
Benign metastasizing leiomyoma (BML) is a rare condition that affects women with 
a history of uterine myomectomy, which is found to metastasize to extra-uterine sites. 
The disease is characterized by monoclonal proliferation of smooth muscle cells and 
haematogenous spread from uterine leiomyoma to distant locations, most commonly 
Figure 1. 
(A) Contrast-enhanced T1-weighted fat-suppressed fast spin echo magnetic resonance image shows multiple 
homogeneously enhancing peritoneal leiomyomas (arrows), (B) Intra-operative gross image showing multiple 




the lungs (Figure 2) [2, 8]. The other uncommon site of metastasis includes heart and 
spinal cord [2]. Metaplastic transformation of the coelomic epithelium may explain 
BML in almost any place where mesothelial mesenchyme exists [2]. BML commonly 
occur during peri-menopausal period. Surgical excision is the treatment of choice.
2.3 Intravenous leiomyomatosis
Intravenous leiomyomatosis (IVL) also included under smooth muscle tumours 
with unusual growth pattern like that of benign metastasizing leiomyoma (BML) 
and diffuse peritoneal leiomyomatosis (DPL) and difficult to distinguish from them 
[2]. IVL is very rare variant of benign leiomyomas. It presents as fragile and mal-
leable leiomyoma that extends through adjacent venous structures in a worm-like 
fashion (Figure 3) [2]. Rarey, IVL may infiltrate into the right heart chamber and 
the lungs [6]. Due to wide range of clinical manifestation, IVL is difficult to diag-
nose pre-operatively [2].
2.4 Parasitic leiomyoma
Parasitic leiomyoma is termed when leiomyoma especially subserous fibroid 
is pedunculated off the uterine serosa or when fragments of a fibroid detach, get 
implanted and grow within the peritoneal cavity or becomes adherent to other 
structures, especially the omentum (Figure 4) [3]. They obtain their blood supply 
from nearby organ and the uterine pedicle either or become avascular and disap-
pear completely. These are also known as ectopic leiomyoma [3]. Cucinella et al. 
suggested morcellated hysterectomies or myomectomies as an important cause for 
development of parasitic leiomyoma [9].
Figure 2. 
(A) Abdomino-pelvic computed tomography showing a large pelvic mass, and (B) thoracic computed 
tomography showing bilateral lung nodules, Gross specimens (C) pelvic mass excision and (D) video-assisted 
thoracoscopic guided surgical resection of bilateral basal lung nodule in an operated case of total abdominal 




Extrauterine adenomyomas (EUA) are benign tumours composed of smooth 
muscles, endometrial glands and endometrial stroma (Figure 5) [10]. In the 
literature, four hypotheses have been proposed for the development of EUA which 
includes (1) Müllerian duct fusion defect - the failure of fusion of Müllerian 
ducts result in either duplication or atresia of the uterus which is suggested by the 
formation of uterine-like masses, (2) Subcoelomic mesenchyme transformation - 
Subcoelomic mesenchyme is a layer of tissue that lies underneath the mesothelial 
surface of the peritoneum. It also lies underneath the subserosal stroma of uterus, 
uterine ligaments, ovaries and fallopian tubes, (3) Müllerianosis - It is a heterotopic 
Müllerian rests incorporated into other organs during organogenesis which may 
proliferate in response to hormones and (4) Endomyometriosis - along with endo-
myometriosis, smooth muscle hyperplasia or metaplasia leads to EUA [11, 12].
3. Role of hormones
Leiomyomas are clonal neoplasm and express more number of estrogen and 
progesterone receptors in comparison to normal myometrium [1, 2]. Circulating 
estrogen, progesterone and other growth factors like epidermal growth factor and 
Figure 3. 
(A) Magnetic resonance image showing a ‘comma’ shaped thrombosis, extending from the intrahepatic portion 
of inferior vena cava (IVC) to the right atrium, (B) Echocardiography showing an intracardiac mass with 
dynamic movement past the tricuspid valve into the right ventricle, (C) Gross specimen of total abdominal 
hysterectomy with left salpingo-oophorectomy, and IVC and intracardiac mass.
Figure 4. 
(A) Magnetic resonance image showing two large lobulated peritoneal masses with similar signal and 
enhancement characteristics, (B) Gross specimen of peritoneal fibroid vascularized by omental vessels in a 




insulin like growth factors are involved in the growth of uterine leiomyomas [1]. 
Estrogen stimulates the growth of leiomyoma independent of its location whether 
uterine or extrauterine [1]. However, the role of progesterone remains uncertain in 
extrauterine leiomyoma and it’s serum levels are either normal or low. Withdrawal 
of progesterone and of sex steroid down regulates expression of estrogen receptors 
(ER) in both leiomyomas and myometrium. This indicates that progesterone and 
progestins have a dual role on leiomyomas. First, limitation of the tissue response 
due to blocking of ER replacement and leading to unopposed estrogenic growth 
effect either by direct stimulation or by increased expression of progesterone recep-
tors (PR). Second, progesterone may leads to an intrinsic growth-stimulation [1]. 
Progesterone causes increased mitotic division causing myoma growth and leads to 
the higher propensity for development of the somatic mutations in the myomas. It is 
suggested that PR is highly expressed in leiomyomas occurring in the reproductive 
period [1]. Such hormones influence rapid increase in size of leiomyoma in preg-
nancy which may lead to fetal wastage. However, there is lower expression of PR in 
EUL than in UL suggesting that different factors may contribute to the development 
of these tumours. Sen et al found a significant difference for labeling indices of 
PR between UL and EUL, however it was not significant for ER. Thus, therapeutic 
models targeting PRs may not be effective on EUL.
4. Diagnosis
Patient may present with menorrhagia, or diagnosed incidentally with the 
history of previous myoma or myomectomy [3]. Ultrasound is useful for diagnosis 
of uterine fibroid. Prior diagnosis of extra-uterine fibroids is often difficult owing 
to non-specific clinical and radiological findings. MRI is very helpful when ultra-
sound shows poor delineation, and in case of rapidly growing fibroid suspicious for 
Figure 5. 
Intra-operative laparoscopic images of (A) pararectal adenomyoma and (B) right ovarian adenomyoma, 
histopathology images of ovarian adenomyoma (C) low power and (D) high power delineating smooth muscle 
bundles with embedded endometrial glands in a patient underwent laparoscopic myomectomy 5 years earlier.
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malignant transformation. MRI is also very useful for the diagnosis of DPL as well 
as to determine its extent of spread for surgical planning (Figure 1A) [3]. In case of 
IVL, apart from trans-vaginal ultrasound, and other modalities such as pelvic MRI, 
trans-thoracic echocardiography, abdomen or chest computed tomography (CT), 
and positron emission tomography (PET) are beneficial [2]. But there is limitation 
of MRI in locating retroperitoneal leiomyoma in which exact anatomical location 
can be often ascertained only intraoperatively [3]. Few cases may turn into leiomyo-
sarcoma. Peritoneal cytology should be done in case of ascites [3].
Despite the extrauterine manifestation of leiomyoma, benign leiomyomas can be 
distinguished from leiomyosarcoma histologically. Sarcoma is marked by high grade 
cellular atypia, mitotic index of greater than 10, and presence of coagulative tumor 
cell necrosis [2]. IVL, usually found within uterine venous channels and micro-
scopically shows benign appearing smooth muscle cells with low mitotic activity 
which stain for actin and desmin [2].
Recent investigations showed that IVL and BML share the same cytogenetic origin, 
demonstrated by comparative genomic hybridization, clonal number, and copy vari-
ance [2]. Leiomyoma and leiomyosarcoma both shows smooth muscle differentiation, 
however biologically they are different in relation to clinical, cytogenetic, and molecu-
lar features [13]. MED12, the mediator complex subunit 12 gene, is a recently described 
oncogene found in both primary and metastatic leiomyosarcoma. It is detected in as 
many as 70% of sporadic uterine leiomyoma [13]. Oncogenic roles of MED 12 gene is 
also detected in smooth muscle tumours arising in extrauterine locations, however, fur-
ther validating studies required for confirming its exact role in their pathogenesis [13].
5. Treatment
Complete surgical excision is considered the mainstay and definitive treatment 
for EULs [14]. LPD mimics carcinomatosis, so total abdominal hysterectomy along 
with bilateral oophorectomy is often the preferred surgical treatment [5]. However, 
spontaneous regression has been also described in few case reports in the literature 
[5]. Surgical treatment affects reproductive ability in pre-menopausal women, 
so it should always be planned considering the family planning of the patient. In 
such situation diagnosis by intra-operative frozen section is very helpful [5]. Young 
patient in child bearing age group, especially who shows positivity for ER or PR 
markers in EUL, should be subject to ovary-sparing procedures and might be ben-
efited from adjuvant therapy using GnRH agonist [2]. In histological proven DPL 
cases, debulking is very effective for relieving symptoms, provided the appropriate 
evaluation of general health conditions of the patient [5]. In unresectable cases of 
EULs, a medical treatment with aromatase inhibitors, chemotherapeutic agents 
or a gonadotropin agonist can be considered [2, 6]. During morcellation, falling 
pieces of myoma fragments should be avoided and proper attention should be given 
during removal via the port site. Post morcellation, reverse trendelenburg position 
should be attempted and thorough inspection with copious peritoneal lavage is 
recommended to aid the removal of remnant myoma pieces [3]. The Food and Drug 
Administration guidelines discourage the uses of laparoscopic power morcellation 
during hysterectomy or myomectomy for the treatment of uterine fibroids [3].
6. Follow-up
A routine follow-up is advised in all the patients of uterine fibroid undergo-
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essential in all the operated cases of EUL, particularly, DPL. In EULs, recurrence, 
if any, usually occur within 6 months after surgical resection. Since, these tumours 
are hormone sensitive, they usually show regression after reduction in estrogen 
exposure like after attainment of menopause. Repeat surgeries for recurrent EULs 
usually entail greater surgical difficulty and risks including visceral injuries [3].
7. Complications
DPL may leads to peritonitis and bowel obstruction which can result into sepsis 
and gangrene. Also, recurrence is not unusual in DPL cases due extensive involve-
ment of peritoneal cavity. Sometimes, malignant transformation may occur in long 
standing cases.
8. Conclusions
EULs possess a great diagnostic challenge due to abnormal locations as well as 
their unusual growth patterns and more commonly associated with the complications 
in comparison to uterine leiomyomas. Though, histologically they show similarities 
with their uterine counter parts, however their pathogenesis is different and yet not 
well understood. These EULs, are hormone sensitive and may regress automatically 
after the recession of hormonal sources, however, this phenomenon is not universal 
in all cases. Due to their higher propensity for recurrence and rare malignant trans-
formation a close follow-up is required. A peritoneal cytology and/or frozen section 
examination is recommended before major surgical procedures in EULs.
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